ORC1L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.544600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.324600E-01
Normal-vs-Stage2
7.878400E-01
Normal-vs-Stage3
4.833000E-01
Normal-vs-Stage4
9.993600E-01
Stage1-vs-Stage2
4.979400E-01
Stage1-vs-Stage3
6.501200E-01
Stage1-vs-Stage4
8.120400E-01
Stage2-vs-Stage3
3.287400E-01
Stage2-vs-Stage4
7.571000E-01
Stage3-vs-Stage4
4.575400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.271600E-01
Normal-vs-AfricanAmerican
7.587400E-01
Normal-vs-Asian
8.533400E-01
Caucasian-vs-AfricanAmerican
5.344800E-01
Caucasian-vs-Asian
8.946400E-01
AfricanAmerican-vs-Asian
5.083200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.526400E-01
Normal-vs-Female
6.968200E-01
Male-vs-Female
5.572200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.846400E-01
Normal-vs-Age(41-60Yrs)
7.341000E-01
Normal-vs-Age(61-80Yrs)
9.841000E-01
Normal-vs-Age(81-100Yrs)
6.107000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.646200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.583650E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.463800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.841810E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.275800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.090800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.753800E-01
Normal-vs-Daily Drinker
8.535000E-01
Normal-vs-Weekly Drinker
8.341400E-01
Normal-vs-Occasional Drinker
6.104000E-01
Normal-vs-Social Drinker
8.766200E-01
Non Drinker-vs-Daily Drinker
8.970000E-01
Non Drinker-vs-Weekly Drinker
8.143600E-01
Non Drinker-vs-Occasional Drinker
5.956200E-01
Non Drinker-vs-Social Drinker
8.418600E-01
Daily Drinker-vs-Weekly Drinker
7.574600E-01
Daily Drinker-vs-Occasional Drinker
4.048000E-01
Daily Drinker-vs-Social Drinker
9.289800E-01
Weekly Drinker-vs-Occasional Drinker
9.410800E-01
Weekly Drinker-vs-Social Drinker
7.316000E-01
Occasional Drinker-vs-Social Drinker
4.016800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.467800E-01
Normal-vs-Grade 2
5.887800E-01
Normal-vs-Grade 3
6.055400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.116400E-03
Grade 1-vs-Grade 3
1.923140E-03
Grade 1-vs-Grade 4
5.467800E-01
Grade 2-vs-Grade 3
3.441800E-01
Grade 2-vs-Grade 4
5.887800E-01
Grade 3-vs-Grade 4
6.055400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.118000E-01
Normal-vs-NonDiabetic
8.792200E-01
Diabetic-vs-NonDiabetic
9.367000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.455200E-01
Normal-vs-NoPancreatitis
8.739400E-01
Pancreatitis-vs-NoPancreatitis
8.450600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.233400E-01
Normal-vs-N1
8.306600E-01
N0-vs-N1
9.482400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.264000E-01
Normal-vs-TP53-NonMutant
9.519000E-01
TP53-Mutant-vs-TP53-NonMutant
3.139700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
